D. E. Shaw & Co., L.P. 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-16 4:04 pm Sale | 2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | D. E. Shaw & Co., L.P. | 1,260,749 1.800% | -2,188,863 (-63.45%) | Filing |
2020-06-05 4:02 pm Purchase | 2020-05-26 | 13G | CymaBay Therapeutics, Inc. CBAY | D. E. Shaw & Co., L.P. | 3,449,612 5.000% | 3,449,612 (New Position) | Filing |